Free licensing of vaccines to end the COVID-19 crisis.

Bozorgmehr, Kayvan; Jahn, Rosa; Stuckler, David; McKee, Martin

Bozorgmehr, Kayvan; Jahn, Rosa; Stuckler, David; McKee, Martin.

Bozorgmehr K; Department of Population Medicine and Health Services Research, School of Public Health, Bielefeld University, D-33501 Bielefeld, Germany; Section for Health Equity Studies and Migration, Department of General Practice and Health Services Research, Heidelberg University Hospital, Heidelberg, Germany
Jahn R; Section for Health Equity Studies and Migration, Department of General Practice and Health Services Research, Heidelberg University Hospital, Heidelberg, Germany.
Stuckler D; Department of Social and Political Sciences, Bocconi University, Milan, Italy.
McKee M; Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.

Lancet ; 397(10281): 1261-1262, 2021 04 03.

Article in English | MEDLINE | ID: covidwho-1621102

Subject(s)

COVID-19 Vaccines/supply & distribution; COVID-19/prevention & control; Drug Industry/legislation & jurisprudence; Licensure; COVID-19/epidemiology; Drug Approval/legislation & jurisprudence; European Union; Humans; Pandemics/prevention & control; Patents as Topic/legislation & jurisprudence; SARS-CoV-2/immunology; United States

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Drug Industry / COVID-19 Vaccines / COVID-19 / Licensure Type of study: Observational study Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: Lancet Year: 2021 Document Type: Article Affiliation country: S0140-6736(21)00467-0

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google